{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:44:19Z","timestamp":1782992659570,"version":"3.54.5"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural science fundation of Zhejiang province","award":["ZCLMS25H2801"],"award-info":[{"award-number":["ZCLMS25H2801"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82404900"],"award-info":[{"award-number":["82404900"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82274134"],"award-info":[{"award-number":["82274134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024M762962"],"award-info":[{"award-number":["2024M762962"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Key Laboratory of Zhejiang Province","award":["2012E10002"],"award-info":[{"award-number":["2012E10002"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The disruption of bone immune function and bone metabolism homeostasis is intricately linked to the onset and progression of glucocorticoid-induced osteoporosis (GIOP). From the perspective of indirect pharmacology, bone immune cells act as critical intermediate mediators that bridge systemic drug exposure and local bone tissue responses. Wubi Shanyao Pills (WBSY), a Chinese patent medicine, have been shown to modulate T lymphocyte levels in naturally aging mice and improve bone strength. However, whether WBSY exerts anti-GIOP effects through an indirect immunomodulatory pattern and its underlying intermediate mechanisms remain unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>This study aims to elucidate the effects and mechanisms of WBSY on GIOP in mice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Initially, the chemical constituents of WBSY were characterized using high-performance liquid chromatography (HPLC). Following this, a GIOP mouse model was developed through intraperitoneal administration of dexamethasone at a dosage of 10\u00a0mg\/kg every three days. The mice were subsequently treated with WBSY at varying dosages\u2014high (1.5\u00a0g\/kg), medium (0.75\u00a0g\/kg), and low (0.375\u00a0g\/kg)\u2014via gavage over a 20-week duration. Throughout the experimental period, general physiological parameters of the mice were systematically monitored. Bone mass alterations were subsequently assessed through bone strength measurements, micro-computed tomography analysis of bone tissue, and histopathological examination. Potential target pathways were identified via transcriptomic analysis. Furthermore, bone immunology-related parameters were evaluated using flow cytometry, including the proportion of T lymphocytes in the spleen and bone marrow, as well as the expression levels of the CXC chemokine ligand 10-chemokine receptor 3 (CXCL10-CXCR3) axis. Concurrently, key indicators of the bone metabolism pathway, such as the Receptor Activator of Nuclear Factor-\u03baB (RANK), Receptor Activator of Nuclear Factor-\u03baB ligand (RANKL), and osteoprotegerin (OPG), were further analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results of the HPLC analysis demonstrated that the concentrations of echinacoside, acteoside, and schisandrol in WBSY were 7.82\u00a0mg\/g, 2.18\u00a0mg\/g, and 0.32\u00a0mg\/g, respectively. Subsequently, the findings revealed that WBSY significantly enhanced general physiological parameters, including body weight, grip strength, and anal\/back temperature, in GIOP mice. WBSY not only enhanced bone strength and mitigated pathological damage to the femur, but also significantly improved bone microarchitecture. This improvement was evidenced by an increase in bone volume\/tissue volume, trabecular thickness, and trabecular number, alongside a reduction in trabecular separation and the structural model index. Furthermore, transcriptomic analysis indicated that WBSY may exert anti-GIOP effects by modulating key pathways, including osteoclast differentiation, interleukin-17A (IL-17A), and nuclear factor kappa B (NF-\u03baB). At the immunological level, WBSY was shown to increase the proportion of T cells, B cells, and CD4\u207a T cells in the spleen, downregulate the expression of CXCL10 and CXCR3, and inhibit the activation of CD4\u207a Th17 cells in the femur. At the molecular level, WBSY modulated the expression of key molecules involved in the bone metabolism pathway, including RANK, RANKL, and OPG. It consistently downregulated the levels of femoral inflammation signaling molecules such as tumor necrosis factor receptor-associated factor 6 (TRAF6), phosphorylated I\u03baB kinase \u03b2\/I\u03baB kinase \u03b2 (p-IKK\u03b2\/IKK\u03b2), and phosphorylated nuclear factor kappa B\/nuclear factor kappa B (p-NF-\u03baB\/NF-\u03baB). Additionally, WBSY reduced the concentrations of bone resorption markers, including tartrate-resistant acid phosphatase (TRAP) and \u03b2-C-telopeptide of type I collagen (\u03b2-CTX). Concurrently, it upregulated the expression of osteogenic molecules such as Runt-related transcription factor 2 (Runx2) and bone morphogenetic protein 2 (BMP2), leading to increased concentrations of bone formation markers, including bone-specific alkaline phosphatase (BALP), procollagen type I N-terminal propeptide (PINP), and osteocalcin (BGP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In summary, this study suggests that WBSY exerts anti-GIOP effects via an indirect pharmacological mechanism. WBSY may modulate the CXCL10-CXCR3 axis to inhibit aberrant T cell homing to the bone marrow, thereby reducing the excessive activation of bone marrow-resident Th17 cells and the secretion of the key bridging cytokine IL-17A. This indirect immunomodulation may subsequently restore the balance of the RANKL\/RANK\/OPG pathway, ultimately synergistically promoting bone formation and inhibiting bone resorption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01452-7","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T10:29:55Z","timestamp":1782988195000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wubi Shanyao Pills ameliorate glucocorticoid-induced osteoporosis by regulating bone marrow T cell homing as an immune intermediate to restore bone metabolism"],"prefix":"10.1186","volume":"21","author":[{"given":"Ying-Jie","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Yue","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Wen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Er-Xiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Yuan","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"issue":"1","key":"1452_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccmp.2023.100122","volume":"4","author":"D-B Asante","year":"2024","unstructured":"Asante D-B, Wiafe GA, Tsegah KM, Domey NK. Therapeutic benefits of vernonia amygdalina in the treatment of inflammation and its associated diseases. Clin Complem Medicine Pharm. 2024;4(1):100122.","journal-title":"Clin Complem Medicine Pharm"},{"issue":"1","key":"1452_CR2","doi-asserted-by":"publisher","first-page":"16155","DOI":"10.1038\/s41598-021-95640-0","volume":"11","author":"H Bhadricha","year":"2021","unstructured":"Bhadricha H, Patel V, Singh AK, Savardekar L, Patil A, Surve S, et al. Increased frequency of Th17 cells and IL-17 levels are associated with low bone mineral density in postmenopausal women. Sci Rep. 2021;11(1):16155.","journal-title":"Sci Rep"},{"issue":"7","key":"1452_CR3","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s00198-016-3561-3","volume":"27","author":"E Cavalier","year":"2016","unstructured":"Cavalier E, Bergmann P, Bruy\u00e8re O, Delanaye P, Durnez A, Devogelaer JP, et al. The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. Osteoporos Int. 2016;27(7):2181\u201395.","journal-title":"Osteoporos Int"},{"issue":"9","key":"1452_CR4","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1002\/jbmr.4644","volume":"37","author":"ML Doolittle","year":"2022","unstructured":"Doolittle ML, Saul D, Kaur J, Rowsey JL, Eckhardt B, Vos S, et al. Skeletal effects of inducible ER\u03b1 deletion in osteocytes in adult mice. J Bone Miner Res. 2022;37(9):1750\u201360.","journal-title":"J Bone Miner Res"},{"key":"1452_CR5","doi-asserted-by":"publisher","first-page":"1448708","DOI":"10.3389\/fbioe.2024.1448708","volume":"12","author":"C Feng","year":"2024","unstructured":"Feng C, Zhang K, Zhan S, Gan Y, Xiang X, Niu W. Mechanical impact of regional structural deterioration and tissue-level compensation on proximal femur trabecular bone. Front Bioeng Biotechnol. 2024;12:1448708.","journal-title":"Front Bioeng Biotechnol"},{"issue":"6","key":"1452_CR6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s11914-024-00890-2","volume":"22","author":"J Gostage","year":"2024","unstructured":"Gostage J, Kostenuik P, Goljanek-Whysall K, Bellantuono I, McCloskey E, Bonnet N. Extra-osseous roles of the RANK-RANKL-OPG axis with a focus on skeletal muscle. Curr Osteoporos Rep. 2024;22(6):632\u201350.","journal-title":"Curr Osteoporos Rep"},{"issue":"2","key":"1452_CR7","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1373\/clinchem.2016.259085","volume":"63","author":"MB Greenblatt","year":"2017","unstructured":"Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem. 2017;63(2):464\u201374.","journal-title":"Clin Chem"},{"issue":"1","key":"1452_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X, Lin M, et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther. 2024;9(1):53.","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"1452_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/jdb8030019","volume":"8","author":"D Halloran","year":"2020","unstructured":"Halloran D, Durbano HW, Nohe A. Bone morphogenetic protein-2 in development and bone homeostasis. J Dev Biol. 2020;8(3):19.","journal-title":"J Dev Biol"},{"key":"1452_CR10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jep.2016.03.033","volume":"185","author":"N Han","year":"2016","unstructured":"Han N, Xu J, Xu F, Liu Z, Yin J. The in vivo effects of a fraction from Dioscorea spongiosa on glucocorticoid-induced osteoporosis. J Ethnopharmacol. 2016;185:53\u20139.","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"1452_CR11","doi-asserted-by":"publisher","first-page":"4870","DOI":"10.1038\/s41467-018-07203-z","volume":"9","author":"Z He","year":"2018","unstructured":"He Z, Zhang J, Huang Z, Du Q, Li N, Zhang Q, et al. Sumoylation of ROR\u03b3t regulates T(H)17 differentiation and thymocyte development. Nat Commun. 2018;9(1):4870.","journal-title":"Nat Commun"},{"issue":"13","key":"1452_CR12","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1111\/jcmm.17399","volume":"26","author":"F Huang","year":"2022","unstructured":"Huang F, Wong P, Li J, Lv Z, Xu L, Zhu G, et al. Osteoimmunology: the correlation between osteoclasts and the Th17\/Treg balance in osteoporosis. J Cell Mol Med. 2022;26(13):3591\u20137.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"1452_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","volume":"126","author":"II Ivanov","year":"2006","unstructured":"Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006;126(6):1121\u201333.","journal-title":"Cell"},{"key":"1452_CR14","doi-asserted-by":"publisher","first-page":"1367806","DOI":"10.3389\/fphar.2024.1367806","volume":"15","author":"S Ji","year":"2024","unstructured":"Ji S, Zhao B, Gao Y, Xie J, Han H, Wu Q, et al. Cinnamaldehyde attenuates streptozocin-induced diabetic osteoporosis in a rat model by modulating netrin-1\/DCC-UNC5B signal transduction. Front Pharmacol. 2024;15:1367806.","journal-title":"Front Pharmacol"},{"issue":"14","key":"1452_CR15","doi-asserted-by":"publisher","first-page":"7995","DOI":"10.3390\/ijms23147995","volume":"23","author":"E Jimi","year":"2022","unstructured":"Jimi E, Katagiri T. Critical roles of NF-\u03baB signaling molecules in bone metabolism revealed by genetic mutations in osteopetrosis. Int J Mol Sci. 2022;23(14):7995.","journal-title":"Int J Mol Sci"},{"key":"1452_CR16","volume":"148","author":"X Jin","year":"2025","unstructured":"Jin X, Su J, Su X, Dong Y, Zhu J, Zhou H, et al. Study on the unique effects of Wubi Shanyao Pills in improving postmenopausal osteoporosis via the \u201cgut-bone\u201d axis. Phytomedicine Int J Phytotherapy Phytopharm. 2025;148:157447.","journal-title":"Phytomedicine Int J Phytotherapy Phytopharm"},{"issue":"10","key":"1452_CR17","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/intimm\/dxae031","volume":"36","author":"T Kanno","year":"2024","unstructured":"Kanno T, Miyako K, Endo Y. Lipid metabolism: a central modulator of ROR\u03b3t-mediated Th17 cell differentiation. Int Immunol. 2024;36(10):487\u201396.","journal-title":"Int Immunol"},{"issue":"1","key":"1452_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12906-018-2331-5","volume":"18","author":"EJ Kim","year":"2018","unstructured":"Kim EJ, Lee H, Kim MH, Yang WM. Inhibition of RANKL-stimulated osteoclast differentiation by Schisandra chinensis through down-regulation of NFATc1 and c-fos expression. BMC Complement Altern Med. 2018;18(1):270.","journal-title":"BMC Complement Altern Med"},{"key":"1452_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2147\/OARRR.S282606","volume":"13","author":"AO Kobza","year":"2021","unstructured":"Kobza AO, Herman D, Papaioannou A, Lau AN, Adachi JD. Understanding and managing corticosteroid-induced osteoporosis. Open Access Rheumatol. 2021;13:177\u201390.","journal-title":"Open Access Rheumatol"},{"issue":"1","key":"1452_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11914-019-00498-x","volume":"17","author":"NE Lane","year":"2019","unstructured":"Lane NE. Glucocorticoid-induced osteoporosis: new insights into the pathophysiology and treatments. Curr Osteoporos Rep. 2019;17(1):1\u20137.","journal-title":"Curr Osteoporos Rep"},{"issue":"8","key":"1452_CR21","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1007\/s00784-022-04484-z","volume":"26","author":"S Lari","year":"2022","unstructured":"Lari S, Hiyari S, de Ara\u00fajo Silva DN, de Brito Bezerra B, Ishii M, Monajemzadeh S, et al. Local delivery of a CXCR3 antagonist decreases the progression of bone resorption induced by LPS injection in a murine model. Clin Oral Investig. 2022;26(8):5163\u20139.","journal-title":"Clin Oral Investig"},{"issue":"3","key":"1452_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4162\/nrp.2024.18.3.309","volume":"18","author":"HS Lee","year":"2024","unstructured":"Lee HS, Jung JI, Hong IK, Jang Y, Kim HB, Kim EJ. Anti-osteoporotic effects of Boswellia serrata gum resin extract in vitro and in vivo. Nutr Res Pract. 2024;18(3):309\u201324.","journal-title":"Nutr Res Pract"},{"issue":"12","key":"1452_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080873","volume":"8","author":"SY Lee","year":"2013","unstructured":"Lee SY, Lee KS, Yi SH, Kook SH, Lee JC. Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-\u03baB pathway and attenuating ROS production. PLoS ONE. 2013;8(12):e80873.","journal-title":"PLoS ONE"},{"issue":"3","key":"1452_CR24","doi-asserted-by":"publisher","first-page":"102224","DOI":"10.1016\/j.isci.2021.102224","volume":"24","author":"J Lehmann","year":"2021","unstructured":"Lehmann J, Thiele S, Baschant U, Rachner TD, Niehrs C, Hofbauer LC, et al. Mice lacking DKK1 in T cells exhibit high bone mass and are protected from estrogen-deficiency-induced bone loss. IScience. 2021;24(3):102224.","journal-title":"IScience"},{"issue":"6","key":"1452_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.phymed.2013.01.001","volume":"20","author":"F Li","year":"2013","unstructured":"Li F, Yang X, Yang Y, Guo C, Zhang C, Yang Z, et al. Antiosteoporotic activity of echinacoside in ovariectomized rats. Phytomedicine. 2013;20(6):549\u201357.","journal-title":"Phytomedicine"},{"issue":"10","key":"1452_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.348","volume":"4","author":"J Li","year":"2013","unstructured":"Li J, Zhang N, Huang X, Xu J, Fernandes JC, Dai K, et al. Dexamethasone shifts bone marrow stromal cells from osteoblasts to adipocytes by C\/EBPalpha promoter methylation. Cell Death Dis. 2013;4(10):e832.","journal-title":"Cell Death Dis"},{"key":"1452_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.111588","volume":"129","author":"M Li","year":"2024","unstructured":"Li M, Niu Y, Tian L, Zhang T, Zhou S, Wang L, et al. Astragaloside IV alleviates macrophage senescence and d-galactose-induced bone loss in mice through STING\/NF-\u03baB pathway. Int Immunopharmacol. 2024;129:111588.","journal-title":"Int Immunopharmacol"},{"key":"1452_CR28","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.2147\/IJGM.S335296","volume":"14","author":"R Li","year":"2021","unstructured":"Li R, Zhu X, Zhang M, Zong G, Zhang K. Association of serum periostin level with classical bone turnover markers and bone mineral density in Shanghai Chinese postmenopausal women with osteoporosis. Int J Gen Med. 2021;14:7639\u201346.","journal-title":"Int J Gen Med"},{"issue":"10","key":"1452_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13291","volume":"55","author":"Y Li","year":"2022","unstructured":"Li Y, Zhuang Q, Tao L, Zheng K, Chen S, Yang Y, et al. Urolithin B suppressed osteoclast activation and reduced bone loss of osteoporosis via inhibiting ERK\/NF-\u03baB pathway. Cell Prolif. 2022;55(10):e13291.","journal-title":"Cell Prolif"},{"key":"1452_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122592","volume":"345","author":"L Liu","year":"2024","unstructured":"Liu L, Xiang C, Li T, Zhao Z, Xiao T, Ouyang Z. Inhibition of NF-\u03baB and ERK signaling pathways in osteoclasts and M1 macrophage polarization: mechanistic insights into the anti-osteoporotic effects of Pseudolaric acid B. Life Sci. 2024;345:122592.","journal-title":"Life Sci"},{"issue":"6","key":"1452_CR31","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/s12276-022-00764-6","volume":"54","author":"P Liu","year":"2022","unstructured":"Liu P, Gao Y, Luo P, Yu H, Guo S, Liu F, et al. Glucocorticoid-induced expansion of classical monocytes contributes to bone loss. Exp Mol Med. 2022;54(6):765\u201376.","journal-title":"Exp Mol Med"},{"issue":"3","key":"1452_CR32","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1089\/ten.teb.2012.0527","volume":"19","author":"TM Liu","year":"2013","unstructured":"Liu TM, Lee EH. Transcriptional regulatory cascades in Runx2-dependent bone development. Tissue Eng Part B Rev. 2013;19(3):254\u201363.","journal-title":"Tissue Eng Part B Rev"},{"key":"1452_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.903657","volume":"10","author":"L Marcadet","year":"2022","unstructured":"Marcadet L, Bouredji Z, Argaw A, Frenette J. The Roles of RANK\/RANKL\/OPG in cardiac, skeletal, and smooth muscles in health and disease. Front Cell Dev Biol. 2022;10:903657.","journal-title":"Front Cell Dev Biol"},{"issue":"10","key":"1452_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12882","volume":"53","author":"S Ni","year":"2020","unstructured":"Ni S, Qian Z, Yuan Y, Li D, Zhong Z, Ghorbani F, et al. Schisandrin a restrains osteoclastogenesis by inhibiting reactive oxygen species and activating Nrf2 signalling. Cell Prolif. 2020;53(10):e12882.","journal-title":"Cell Prolif"},{"key":"1452_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bone.2014.05.017","volume":"66","author":"R Niimi","year":"2014","unstructured":"Niimi R, Kono T, Nishihara A, Hasegawa M, Matsumine A, Kono T, et al. Determinants associated with bone mineral density increase in response to daily teriparatide treatment in patients with osteoporosis. Bone. 2014;66:26\u201330.","journal-title":"Bone"},{"issue":"1","key":"1452_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/cr.2010.159","volume":"21","author":"DV Novack","year":"2011","unstructured":"Novack DV. Role of NF-\u03baB in the skeleton. Cell Res. 2011;21(1):169\u201382.","journal-title":"Cell Res"},{"key":"1452_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2023.116675","volume":"168","author":"K Okamoto","year":"2023","unstructured":"Okamoto K, Takayanagi H. Effect of T cells on bone. Bone. 2023;168:116675.","journal-title":"Bone"},{"key":"1452_CR38","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.2147\/DDDT.S377001","volume":"16","author":"X Rong","year":"2022","unstructured":"Rong X, Kou Y, Zhang Y, Yang P, Tang R, Liu H, et al. ED-71 prevents glucocorticoid-induced osteoporosis by regulating osteoblast differentiation via notch and Wnt\/\u03b2-catenin pathways. Drug Des Devel Ther. 2022;16:3929\u201346.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"1452_CR39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/antiox13010066","volume":"13","author":"SR Saleh","year":"2024","unstructured":"Saleh SR, Saleh OM, El-Bessoumy AA, Sheta E, Ghareeb DA, Eweda SM. The therapeutic potential of two Egyptian plant extracts for mitigating dexamethasone-induced osteoporosis in rats: Nrf2\/HO-1 and RANK\/RANKL\/OPG signals. Antioxidants. 2024;13(1):66.","journal-title":"Antioxidants"},{"issue":"5","key":"1452_CR40","first-page":"01","volume":"9","author":"D Satyanarayanasetty","year":"2015","unstructured":"Satyanarayanasetty D, Pawar K, Nadig P, Haran A. Multiple adverse effects of systemic corticosteroids: a case report. J Clin Diagn Res. 2015;9(5):01\u20132.","journal-title":"J Clin Diagn Res"},{"issue":"4","key":"1452_CR41","doi-asserted-by":"publisher","first-page":"200181","DOI":"10.1016\/j.ctmp.2024.200181","volume":"5","author":"K Shao","year":"2024","unstructured":"Shao K, Dong N, Li Z, Wu D, Li H, Liu Q, et al. Precise diagnosis classification based on a \u201ctwo types and six syndromes\u201d approach of aplastic anemia (Sui Lao disease) and their pathological characteristics: a multicenter retrospective study. Clin Tradi Med Pharmacol. 2024;5(4):200181.","journal-title":"Clin Tradi Med Pharmacol"},{"issue":"1","key":"1452_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41419-020-03249-4","volume":"12","author":"L Song","year":"2020","unstructured":"Song L, Cao L, Liu R, Ma H, Li Y, Shang Q, et al. The critical role of T cells in glucocorticoid-induced osteoporosis. Cell Death Dis. 2020;12(1):45.","journal-title":"Cell Death Dis"},{"issue":"13","key":"1452_CR43","first-page":"1836","volume":"30","author":"WG Song","year":"2010","unstructured":"Song WG, Sun FJ, Wang CC, Li GH. Protective effect of Pueraria lobata extract on dexamethasone-induced osteoporosis model in rats. Chin J Gerontol. 2010;30(13):1836\u20138.","journal-title":"Chin J Gerontol"},{"issue":"10","key":"1452_CR44","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s40266-024-01143-8","volume":"41","author":"K Sparling","year":"2024","unstructured":"Sparling K, Butler DC. Oral corticosteroids for skin disease in the older population: minimizing potential adverse effects. Drugs Aging. 2024;41(10):795\u2013808.","journal-title":"Drugs Aging"},{"key":"1452_CR45","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3389\/fimmu.2018.00657","volume":"9","author":"RK Srivastava","year":"2018","unstructured":"Srivastava RK, Dar HY, Mishra PK. Immunoporosis: Immunology of osteoporosis-role of T Cells. Front Immunol. 2018;9:657.","journal-title":"Front Immunol"},{"issue":"1","key":"1452_CR46","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00198-016-3785-2","volume":"28","author":"Y Su","year":"2017","unstructured":"Su Y, Leung J, Hans D, Aubry-Rozier B, Kwok T. Added clinical use of trabecular bone score to BMD for major osteoporotic fracture prediction in older Chinese people: the Mr. OS and Ms. OS cohort study in Hong Kong. Osteoporosis Int. 2017;28(1):151\u201360.","journal-title":"Osteoporosis Int"},{"key":"1452_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.629968","volume":"12","author":"K Sun","year":"2021","unstructured":"Sun K, Zhu J, Deng Y, Xu X, Kong F, Sun X, et al. Gamabufotalin inhibits osteoclastgenesis and counteracts estrogen-deficient bone loss in mice by suppressing rankl-induced NF-\u03baB and ERK\/MAPK pathways. Front Pharmacol. 2021;12:629968.","journal-title":"Front Pharmacol"},{"issue":"2","key":"1452_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00774-024-01502-w","volume":"42","author":"Y Tanaka","year":"2024","unstructured":"Tanaka Y, Soen S, Hirata S, Okada Y, Fujiwara S, Tanaka I, et al. The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis. J Bone Miner Metab. 2024;42(2):143\u201354.","journal-title":"J Bone Miner Metab"},{"issue":"5","key":"1452_CR49","first-page":"3644","volume":"17","author":"Y Wang","year":"2019","unstructured":"Wang Y, Ma Z, Zheng Y, Liu B, Bao P, Wu X, et al. Establishment of an osteoporosis model in tree shrews by bilateral ovariectomy and comprehensive evaluation. Exp Ther Med. 2019;17(5):3644\u201354.","journal-title":"Exp Ther Med"},{"key":"1452_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112605","volume":"146","author":"JX Wei","year":"2022","unstructured":"Wei JX, Luo Y, Xu Y, Xiao JH. Osteoinductive activity of bisdemethoxycurcumin and its synergistic protective effect with human amniotic mesenchymal stem cells against ovariectomy-induced osteoporosis mouse model. Biomed Pharmacother. 2022;146:112605.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1452_CR51","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s00441-021-03496-7","volume":"386","author":"Y Wei","year":"2021","unstructured":"Wei Y, Fu J, Wu W, Ma P, Ren L, Wu J. Estrogen prevents cellular senescence and bone loss through Usp10-dependent p53 degradation in osteocytes and osteoblasts: the role of estrogen in bone cell senescence. Cell Tissue Res. 2021;386(2):297\u2013308.","journal-title":"Cell Tissue Res"},{"issue":"6","key":"1452_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.53388\/TMR20231227001","volume":"9","author":"M-M Wu","year":"2024","unstructured":"Wu M-M, He X-P, Wu W-T, Lu W-J, Mai Y-Y, Xu K-C, et al. A comparison of the effect of alendronate and You-Gui-Wan on osteoporosis in female rats with kidney-yang deficiency. Tradit Med Res. 2024;9(6):31\u201341.","journal-title":"Tradit Med Res"},{"issue":"21","key":"1452_CR53","doi-asserted-by":"publisher","first-page":"21706","DOI":"10.18632\/aging.103976","volume":"12","author":"L Xiao","year":"2020","unstructured":"Xiao L, Zhong M, Huang Y, Zhu J, Tang W, Li D, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6\/ROS-dependent MAPK\/NF-\u03baB signaling pathways. Aging. 2020;12(21):21706\u201329.","journal-title":"Aging"},{"issue":"1","key":"1452_CR54","doi-asserted-by":"crossref","DOI":"10.3892\/etm.2021.11023","volume":"403","author":"Q Xing","year":"2021","unstructured":"Xing Q, Feng J, Zhang X. Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3\/Akt pathway. Exp Ther Med. 2021;403(1):112595.","journal-title":"Exp Ther Med"},{"issue":"9","key":"1452_CR55","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3390\/md23090356","volume":"23","author":"W Yang","year":"2025","unstructured":"Yang W, Ma W, Qin X, Cao W, Lin H. Improvement effect and regulation mechanism of oyster peptide on dexamethasone-induced osteoporotic rats. Mar Drugs. 2025;23(9):356.","journal-title":"Mar Drugs"},{"issue":"1","key":"1452_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41419-023-05565-x","volume":"14","author":"Y You","year":"2023","unstructured":"You Y, Liu J, Zhang L, Li X, Sun Z, Dai Z, et al. WTAP-mediated m(6)A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis. Cell Death Dis. 2023;14(1):33.","journal-title":"Cell Death Dis"},{"issue":"4","key":"1452_CR57","doi-asserted-by":"publisher","DOI":"10.1172\/JCI143137","volume":"131","author":"M Yu","year":"2021","unstructured":"Yu M, Pal S, Paterson CW, Li JY, Tyagi AM, Adams J, et al. Ovariectomy induces bone loss via microbial-dependent trafficking of intestinal TNF+ T cells and Th17 cells. J Clin Invest. 2021;131(4):e143137.","journal-title":"J Clin Invest"},{"issue":"6","key":"1452_CR58","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.jpha.2023.05.009","volume":"13","author":"J Zeng","year":"2023","unstructured":"Zeng J, Li M, Zhao Q, Chen M, Zhao L, Wei S, et al. Small molecule inhibitors of ROR\u03b3t for Th17 regulation in inflammatory and autoimmune diseases. J Pharm Anal. 2023;13(6):545\u201362.","journal-title":"J Pharm Anal"},{"key":"1452_CR59","doi-asserted-by":"publisher","first-page":"1018480","DOI":"10.3389\/fphar.2022.1018480","volume":"13","author":"H Zhang","year":"2022","unstructured":"Zhang H, Ke Z, Dong S, Du Y, Tang W, Chen M, et al. Eldecalcitol prevents muscle loss by suppressing PI3K\/AKT\/FOXOs pathway in orchiectomized mice. Front Pharmacol. 2022;13:1018480.","journal-title":"Front Pharmacol"},{"key":"1452_CR60","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3389\/fendo.2020.00465","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang W, Dang K, Huai Y, Qian A. Osteoimmunology: the regulatory roles of T lymphocytes in osteoporosis. Front Endocrinol. 2020;11:465.","journal-title":"Front Endocrinol"},{"key":"1452_CR61","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12979-020-00202-z","volume":"17","author":"L Zhu","year":"2020","unstructured":"Zhu L, Hua F, Ding W, Ding K, Zhang Y, Xu C. The correlation between the Th17\/Treg cell balance and bone health. Immun Ageing. 2020;17:30.","journal-title":"Immun Ageing"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01452-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01452-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T11:01:51Z","timestamp":1782990111000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01452-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1452"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01452-7","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"178"}}